Literature DB >> 31940172

Synthetic Liposomal Mimics of Biological Viruses for the Study of Immune Responses to Infection and Vaccination.

Wei-Yun Wholey1, James L Mueller2, Corey Tan2, Jeremy F Brooks2, Julie Zikherman2, Wei Cheng1,3.   

Abstract

Human viruses possess very complex supramolecular structures. Both icosahedral and enveloped viruses typically display an array of viral-encoded protein antigens at varied spatial densities on the viral particle surface. The viral nucleic acid genome, on the other hand, is encapsulated inside the viral particle. Although both the surface antigen and the interior nucleic acids could independently produce immunological responses, how B cells integrate these two types of signals and respond to a typical virus particle to initiate activation is not well understood at a molecular level. The study of these fundamental biological processes would benefit from the development of viral structural mimics that are well constructed to incorporate both quantitative and qualitative viral features for presentation to B cells. These novel tools would enable researchers to systematically dissect the underlying processes. Here we report the development of such particulate antigens based on liposomes engineered to display a model protein antigen, hen egg lysozyme (HEL). We developed methods to overexpress and purify various affinity mutants of HEL from E. coli. We conjugated the purified recombinant HEL proteins onto the surface of a virion-sized liposome in an orientation-specific manner at defined spatial densities and also encapsulated nucleic acid molecules into the interior of the liposome. Both the chemical conjugation of the HEL antigen on liposome surfaces and the encapsulation of nucleic acids were stable under physiologically relevant conditions. These liposomes elicited antigen-specific B-cell responses in vitro, which validate these supramolecular structures as a novel and effective approach to mimic and systematically isolate the role of essential viral features in directing the B-cell response to particulate antigens.

Entities:  

Year:  2020        PMID: 31940172      PMCID: PMC7422769          DOI: 10.1021/acs.bioconjchem.9b00825

Source DB:  PubMed          Journal:  Bioconjug Chem        ISSN: 1043-1802            Impact factor:   4.774


  66 in total

1.  The transition state in the folding-unfolding reaction of four species of three-disulfide variant of hen lysozyme: the role of each disulfide bridge.

Authors:  A Yokota; K Izutani; M Takai; Y Kubo; Y Noda; Y Koumoto; H Tachibana; S Segawa
Journal:  J Mol Biol       Date:  2000-02-04       Impact factor: 5.469

2.  Immunological studies on egg white proteins. IV. Immunochemical and physical studies of lysozyme.

Authors:  L R WETTER; H F DEUTSCH
Journal:  J Biol Chem       Date:  1951-09       Impact factor: 5.157

3.  Conjugation site modulates the in vivo stability and therapeutic activity of antibody-drug conjugates.

Authors:  Ben-Quan Shen; Keyang Xu; Luna Liu; Helga Raab; Sunil Bhakta; Margaret Kenrick; Kathryn L Parsons-Reponte; Janet Tien; Shang-Fan Yu; Elaine Mai; Dongwei Li; Jay Tibbitts; Jakub Baudys; Ola M Saad; Suzie J Scales; Paul J McDonald; Philip E Hass; Charles Eigenbrot; Trung Nguyen; Willy A Solis; Reina N Fuji; Kelly M Flagella; Darshana Patel; Susan D Spencer; Leslie A Khawli; Allen Ebens; Wai Lee Wong; Richard Vandlen; Surinder Kaur; Mark X Sliwkowski; Richard H Scheller; Paul Polakis; Jagath R Junutula
Journal:  Nat Biotechnol       Date:  2012-01-22       Impact factor: 54.908

4.  Vesicles of variable sizes produced by a rapid extrusion procedure.

Authors:  L D Mayer; M J Hope; P R Cullis
Journal:  Biochim Biophys Acta       Date:  1986-06-13

5.  Tunable degradation of maleimide-thiol adducts in reducing environments.

Authors:  Aaron D Baldwin; Kristi L Kiick
Journal:  Bioconjug Chem       Date:  2011-09-26       Impact factor: 4.774

6.  The influence of antigen organization on B cell responsiveness.

Authors:  M F Bachmann; U H Rohrer; T M Kündig; K Bürki; H Hengartner; R M Zinkernagel
Journal:  Science       Date:  1993-11-26       Impact factor: 47.728

7.  BCR-mediated uptake of antigen linked to TLR9 ligand stimulates B-cell proliferation and antigen-specific plasma cell formation.

Authors:  Julia Eckl-Dorna; Facundo D Batista
Journal:  Blood       Date:  2009-01-14       Impact factor: 22.113

8.  Trastuzumab emtansine: the first targeted chemotherapy for treatment of breast cancer.

Authors:  Parvin F Peddi; Sara A Hurvitz
Journal:  Future Oncol       Date:  2013-03       Impact factor: 3.404

9.  Self-Antigens Displayed on Liposomal Nanoparticles above a Threshold of Epitope Density Elicit Class-Switched Autoreactive Antibodies Independent of T Cell Help.

Authors:  Zhilin Chen; Wei-Yun Wholey; Alireza Hassani Najafabadi; James J Moon; Irina Grigorova; Bryce Chackerian; Wei Cheng
Journal:  J Immunol       Date:  2019-12-13       Impact factor: 5.422

10.  Germinal center antibody mutation trajectories are determined by rapid self/foreign discrimination.

Authors:  Deborah L Burnett; David B Langley; Peter Schofield; Jana R Hermes; Tyani D Chan; Jennifer Jackson; Katherine Bourne; Joanne H Reed; Kate Patterson; Benjamin T Porebski; Robert Brink; Daniel Christ; Christopher C Goodnow
Journal:  Science       Date:  2018-04-13       Impact factor: 47.728

View more
  6 in total

1.  Site-Specific and Stable Conjugation of the SARS-CoV-2 Receptor-Binding Domain to Liposomes in the Absence of Any Other Adjuvants Elicits Potent Neutralizing Antibodies in BALB/c Mice.

Authors:  Wei-Yun Wholey; Sekou-Tidiane Yoda; Wei Cheng
Journal:  Bioconjug Chem       Date:  2021-11-14       Impact factor: 4.774

2.  Lipid Membrane-Based Antigen Presentation to B Cells Using a Fully Synthetic Ex Vivo Germinal Center Model.

Authors:  Liana Kramer; Hannah W Song; Kaiya Mitchell; Mythili Kartik; Ritika Jain; Victoria Lozano Escarra; Enrique Quiros; Harrison Fu; Ankur Singh; Krishnendu Roy
Journal:  Adv Nanobiomed Res       Date:  2022-04-28

3.  DNA-Directed Patterning for Versatile Validation and Characterization of a Lipid-Based Nanoparticle Model of SARS-CoV-2.

Authors:  Molly Kozminsky; Thomas R Carey; Lydia L Sohn
Journal:  Adv Sci (Weinh)       Date:  2021-10-21       Impact factor: 17.521

4.  Potential of Flavonoid-Inspired Phytomedicines against COVID-19.

Authors:  Wilfred Ngwa; Rajiv Kumar; Daryl Thompson; William Lyerly; Roscoe Moore; Terry-Elinor Reid; Henry Lowe; Ngeh Toyang
Journal:  Molecules       Date:  2020-06-11       Impact factor: 4.411

Review 5.  Nanomedicine strategies to target coronavirus.

Authors:  Marcel Alexander Heinrich; Byron Martina; Jai Prakash
Journal:  Nano Today       Date:  2020-08-31       Impact factor: 18.962

6.  NR4A nuclear receptors restrain B cell responses to antigen when second signals are absent or limiting.

Authors:  Corey Tan; Ryosuke Hiwa; James L Mueller; Vivasvan Vykunta; Kenta Hibiya; Mark Noviski; John Huizar; Jeremy F Brooks; Jose Garcia; Cheryl Heyn; Zhongmei Li; Alexander Marson; Julie Zikherman
Journal:  Nat Immunol       Date:  2020-08-31       Impact factor: 25.606

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.